Get the app!
Back to Trades
Sell4

REGENERON PHARMACEUTICALS, INC.

REGN

Total Value
$1.1M
Net $570.0K sold
Sales
$570.0K
1 transaction

Company Information

Ticker Symbol
REGN
CIK
0000872589

Insider Information

Role
Director
Director
Location
TARRYTOWN, NY

Filing Details

Filing Date
Nov 24, 2025
Transaction Date
Nov 20, 2025
Accession Number
0001683607-25-000006
Form Type
4
Net Trading Amount
-$570.0K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Nov 20, 2025Common Stock760$371.40Exercise$282.3K
Nov 20, 2025Common Stock760$750.00Sale$570.0K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Nov 20, 2025Derivative760$371.40Exercise$282.3K

Footnotes

  1. (F1)Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 2, 2025.
  2. (F2)On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.